PFO
CNMD icon

Pathstone Family Office’s CONMED CNMD Stock Holding History

Pathstone Family Office’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5
Closed -$1K – 797
2020
Q4 		$1K Hold
5
– – ﹤0.01% 1076
2020
Q3 		$0 Sell
5
-5
-50% -$408 ﹤0.01% 825
2020
Q2 		$0 Buy
+10
New +$696 ﹤0.01% 755

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Pathstone Family Office's CNMD Position: Q1 2021 in Review

Pathstone Family Office sold out of CONMED (CNMD) in Q1 2021, closing a stake of 5 shares — an estimated $1K sold.

Pathstone Family Office first reported a position in CNMD in Q2 2020 and held it in 3 quarters. The position peaked at $1K in Q4 2020. 239 funds tracked by Wall St. Rank hold CNMD as of Q1 2021.

  • Pathstone Family Office reported no remaining CONMED position as of Q1 2021 after selling out during the quarter.
  • Pathstone Family Office sold 5 CONMED shares in Q1 2021, an estimated $1K.
  • Pathstone Family Office first reported a position in CONMED in Q2 2020 and held it in 3 quarters.
  • Pathstone Family Office's CONMED position peaked at $1K in Q4 2020.
  • 239 funds tracked by Wall St. Rank held CONMED as of Q1 2021.

Based on Pathstone Family Office's 13F filing for Q1 2021, filed 14 May 2021.